Journey Medical (DERM) Total Non-Current Liabilities (2020 - 2024)

Journey Medical has reported Total Non-Current Liabilities for 5 years, with the latest figure at $60.2 million in Q4 2024.

• For the quarter ending Q4 2024, Total Non-Current Liabilities rose 6.5% year-over-year to $60.2 million; the trailing twelve-month figure through Dec 2024 stood at $60.2 million (up 6.5% YoY), and the FY2024 full-year result was $60.2 million, up 6.5% from the prior year.
• Total Non-Current Liabilities for Q4 2024 stood at $60.2 million, up from $56.5 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $97.2 million in Q3 2021, with the low at $41.5 million in Q4 2020.
• Historically, Total Non-Current Liabilities has averaged $71.2 million across 5 years, with a median of $74.9 million in 2022.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 68.11% — and 2023, when it sank 34.88%.
• Journey Medical's Total Non-Current Liabilities stood at $41.5 million in 2020, then grew by 24.33% to $51.6 million in 2021, then soared by 68.11% to $86.8 million in 2022, then sank by 34.88% to $56.5 million in 2023, then rose by 6.5% to $60.2 million in 2024.
• The last three Total Non-Current Liabilities figures came in at $60.2 million (Q4 2024), $56.5 million (Q4 2023), and $69.6 million (Q2 2023), per Business Quant data.